Switch to:
More From Other Websites
QIAGEN NV – Value Analysis (NASDAQ:QGEN) : January 19, 2017 Jan 19 2017
QIAGEN Announces Details for Completion of Approximately $250 Million Synthetic Share Repurchase Jan 18 2017
QIAGEN NV breached its 50 day moving average in a Bearish Manner : QGEN-US : January 18, 2017 Jan 18 2017
QIAGEN N.V. to Report Fourth Quarter and Full Year of 2016 Results Jan 18 2017
Singulex Enters into Collaboration with QIAGEN to Develop Companion Diagnostics Jan 10 2017
QIAGEN (QGEN) Buys OmicSoft, Expands Bioinformatics Suite Jan 10 2017
QIAGEN Enhances Bioinformatics Portfolio with Acquisition of OmicSoft Jan 09 2017
QIAGEN Announces Comprehensive Range of Enhancements for GeneReader NGS System Jan 09 2017
QIAGEN Submits QuantiFERON®-TB Gold Plus for U.S. Regulatory Approval Jan 09 2017
Qiagen Poised on Fundamentals, Expansion Plans on Track Dec 23 2016
QIAGEN Welcomes New Evidence-Based Tuberculosis Testing Guidelines from U.S. Professional Societies Dec 12 2016
Qiagen NV (QGEN) Hedge Funds Are Snapping Up Dec 07 2016
QIAGEN launches unique CALR mutation assay for MPN diagnosis Dec 01 2016
QIAGEN and CosmosID launch new plugin for metagenomics analysis Nov 23 2016
QIAGEN and CosmosID Launch New Plugin for Metagenomics Analysis Nov 22 2016
HTG Molecular Diagnostics and QIAGEN Team Up to Advance Precision Diagnostics Nov 16 2016
HTG Molecular Diagnostics and QIAGEN Team Up to Advance Precision Diagnostics Nov 16 2016
ETFs with exposure to QIAGEN NV : November 14, 2016 Nov 14 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK